login

The D3 Dopamine Receptor: Neurobiology and Potential Clinical Relevance

Pharmacological ReviewsPublished 1 September 1997
Beth Levant
Citations388
SJR quartileQ1
SJR score6.60
SNIP4.90

TL;DR

Receptors for this catecholamine are of considerable interest, as they are the principal target of drugs employed in the treatment of neuropsychiatric disorders such as schizophrenia and Parkinson’s disease.

Abstract

Dopamine is a major neurotransmitter in the central nervous system. Receptors for this catecholamine are of considerable interest, as they are the principal target of drugs employed in the treatment of neuropsychiatric disorders such as schizophrenia and Parkinson’s disease. Before 1990, the

Keywords

MedicineNeuroscience